| telomere capping | GO:0016233 | 4 | 0.961 | |
| telomere maintenance in response to dna damage | GO:0043247 | 4 | 0.777 | |
| dna metabolic process | GO:0006259 | 303 | 0.733 | |
| protection from non homologous end joining at telomere | GO:0031848 | 4 | 0.719 | |
| telomere maintenance | GO:0000723 | 19 | 0.483 | |
| v d j recombination | GO:0033151 | 14 | 0.360 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.308 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.293 | |
| phosphatidylinositol metabolic process | GO:0046488 | 45 | 0.285 | |
| somatic diversification of t cell receptor genes | GO:0002568 | 5 | 0.252 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.215 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.213 | |
| dna recombination | GO:0006310 | 92 | 0.207 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.207 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.190 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.181 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.171 | |
| mrna metabolic process | GO:0016071 | 84 | 0.169 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.158 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.155 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.151 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.149 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.146 | |
| t cell differentiation | GO:0030217 | 174 | 0.145 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.133 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.131 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.128 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.127 | |
| b cell differentiation | GO:0030183 | 78 | 0.126 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.120 | |
| amine metabolic process | GO:0009308 | 45 | 0.120 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.120 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.119 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.119 | |
| gland development | GO:0048732 | 330 | 0.119 | |
| b cell activation | GO:0042113 | 161 | 0.119 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.114 | |
| dna repair | GO:0006281 | 107 | 0.113 | |
| t cell activation | GO:0042110 | 289 | 0.112 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.111 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.111 | |
| regulation of cell activation | GO:0050865 | 289 | 0.107 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.107 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.106 | |
| photoreceptor cell maintenance | GO:0045494 | 19 | 0.106 | |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.105 | |
| segmentation | GO:0035282 | 93 | 0.104 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.103 | |
| regionalization | GO:0003002 | 337 | 0.103 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.099 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.097 | |
| protein catabolic process | GO:0030163 | 221 | 0.096 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.094 | |
| neuron death | GO:0070997 | 154 | 0.094 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.094 | |
| response to radiation | GO:0009314 | 165 | 0.093 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.091 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.091 | |
| phosphatidylinositol biosynthetic process | GO:0006661 | 15 | 0.090 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.090 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.088 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.082 | |
| skeletal system development | GO:0001501 | 356 | 0.081 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 56 | 0.079 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.078 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.078 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.078 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.075 | |
| glycerophospholipid biosynthetic process | GO:0046474 | 32 | 0.074 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.074 | |
| regulation of defense response | GO:0031347 | 233 | 0.072 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.071 | |
| somitogenesis | GO:0001756 | 69 | 0.071 | |
| cell fate commitment | GO:0045165 | 210 | 0.070 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.070 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.070 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.069 | |
| double strand break repair | GO:0006302 | 48 | 0.068 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.068 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.067 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.066 | |
| rna catabolic process | GO:0006401 | 29 | 0.066 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.066 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.065 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.064 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.063 | |
| phosphatidylinositol 3 phosphate biosynthetic process | GO:0036092 | 6 | 0.063 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.060 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.060 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.059 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.058 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.057 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.056 | |
| tissue homeostasis | GO:0001894 | 115 | 0.055 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.055 | |
| t cell receptor v d j recombination | GO:0033153 | 5 | 0.055 | |
| regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032434 | 40 | 0.054 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.054 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.054 | |
| muscle tissue development | GO:0060537 | 308 | 0.051 | |
| dna catabolic process exonucleolytic | GO:0000738 | 3 | 0.050 | |
| phospholipid biosynthetic process | GO:0008654 | 36 | 0.050 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.050 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.049 | |
| cellular response to radiation | GO:0071478 | 28 | 0.049 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.049 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.048 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.048 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.048 | |
| lipoprotein catabolic process | GO:0042159 | 7 | 0.048 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.047 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.047 | |
| inflammatory response | GO:0006954 | 244 | 0.047 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.047 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.046 | |
| urogenital system development | GO:0001655 | 261 | 0.046 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.045 | |
| protein processing | GO:0016485 | 163 | 0.045 | |
| male gamete generation | GO:0048232 | 285 | 0.045 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.044 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.044 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.044 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.044 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.044 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.043 | |
| regulation of protein localization | GO:0032880 | 231 | 0.043 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.043 | |
| fat cell differentiation | GO:0045444 | 160 | 0.043 | |
| stem cell development | GO:0048864 | 219 | 0.043 | |
| regulation of protein processing | GO:0070613 | 96 | 0.043 | |
| cell aging | GO:0007569 | 35 | 0.043 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.042 | |
| cytokine production | GO:0001816 | 319 | 0.042 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.041 | |
| response to nutrient levels | GO:0031667 | 109 | 0.041 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.041 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.040 | |
| organelle fission | GO:0048285 | 170 | 0.040 | Worm |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.040 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.040 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.040 | |
| response to gamma radiation | GO:0010332 | 22 | 0.039 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.039 | |
| somatic recombination of t cell receptor gene segments | GO:0002681 | 5 | 0.039 | |
| somite development | GO:0061053 | 81 | 0.039 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.039 | |
| response to oxidative stress | GO:0006979 | 123 | 0.039 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.039 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.038 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.038 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.038 | |
| mapk cascade | GO:0000165 | 281 | 0.038 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.038 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.038 | |
| response to growth factor | GO:0070848 | 198 | 0.038 | |
| limb morphogenesis | GO:0035108 | 149 | 0.037 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.037 | |
| negative regulation of b cell activation | GO:0050869 | 27 | 0.037 | |
| retina homeostasis | GO:0001895 | 23 | 0.037 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.037 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.036 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.036 | |
| appendage development | GO:0048736 | 166 | 0.036 | |
| mrna catabolic process | GO:0006402 | 22 | 0.036 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.036 | |
| regulation of protein stability | GO:0031647 | 52 | 0.036 | |
| regulation of cell motility | GO:2000145 | 236 | 0.036 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.035 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.035 | |
| camera type eye development | GO:0043010 | 266 | 0.035 | |
| cell division | GO:0051301 | 120 | 0.035 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.035 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.035 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.034 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.034 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.034 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.034 | |
| innate immune response | GO:0045087 | 157 | 0.034 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.034 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.033 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.033 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.033 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.033 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.033 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.033 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.033 | |
| skin development | GO:0043588 | 220 | 0.033 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.032 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.032 | |
| limb development | GO:0060173 | 166 | 0.032 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.032 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.032 | |
| cellular homeostasis | GO:0019725 | 240 | 0.032 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.032 | |
| spermatogenesis | GO:0007283 | 284 | 0.032 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.031 | |
| regulation of neuron death | GO:1901214 | 134 | 0.031 | |
| immature b cell differentiation | GO:0002327 | 10 | 0.031 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.031 | |
| chromosome separation | GO:0051304 | 14 | 0.031 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.031 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.030 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.030 | |
| dna catabolic process | GO:0006308 | 19 | 0.030 | |
| histone mrna metabolic process | GO:0008334 | 3 | 0.030 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.030 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.030 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.030 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.030 | |
| cation transport | GO:0006812 | 399 | 0.030 | |
| protein ubiquitination | GO:0016567 | 171 | 0.030 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.029 | |
| sensory perception | GO:0007600 | 245 | 0.029 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.029 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.029 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.029 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.029 | |
| hindbrain development | GO:0030902 | 128 | 0.029 | |
| telencephalon development | GO:0021537 | 186 | 0.029 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.029 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.028 | |
| positive regulation of neuron apoptotic process | GO:0043525 | 25 | 0.028 | |
| organelle assembly | GO:0070925 | 177 | 0.028 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.028 | |
| transmembrane transport | GO:0055085 | 412 | 0.028 | |
| forebrain development | GO:0030900 | 302 | 0.028 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.028 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.028 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.027 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.027 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.027 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.027 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.027 | |
| epidermis development | GO:0008544 | 187 | 0.027 | |
| negative regulation of t helper 2 cell differentiation | GO:0045629 | 4 | 0.027 | |
| cell growth | GO:0016049 | 130 | 0.027 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.027 | |
| oxidation reduction process | GO:0055114 | 342 | 0.027 | |
| regulation of cell migration | GO:0030334 | 219 | 0.026 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.026 | |
| gliogenesis | GO:0042063 | 141 | 0.026 | |
| rna processing | GO:0006396 | 105 | 0.026 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.026 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.026 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.026 | |
| cation homeostasis | GO:0055080 | 212 | 0.026 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 22 | 0.026 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.026 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.026 | |
| circadian rhythm | GO:0007623 | 114 | 0.026 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.026 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.026 | |
| dna modification | GO:0006304 | 50 | 0.025 | |
| positive regulation of growth | GO:0045927 | 104 | 0.025 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.025 | |
| connective tissue development | GO:0061448 | 179 | 0.025 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.025 | |
| cellular response to lipid | GO:0071396 | 145 | 0.024 | |
| regulation of chromosome segregation | GO:0051983 | 21 | 0.024 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.024 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.024 | |
| ear development | GO:0043583 | 200 | 0.024 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.024 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.024 | |
| cerebral cortex development | GO:0021987 | 86 | 0.024 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.024 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.024 | |
| developmental maturation | GO:0021700 | 193 | 0.024 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.024 | |
| chromatin organization | GO:0006325 | 206 | 0.024 | |
| regulation of ion transport | GO:0043269 | 215 | 0.024 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.024 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.024 | |
| protein maturation | GO:0051604 | 176 | 0.024 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.024 | |
| circulatory system process | GO:0003013 | 197 | 0.024 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.024 | |
| female sex differentiation | GO:0046660 | 84 | 0.024 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.024 | |
| regulation of cell growth | GO:0001558 | 91 | 0.024 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.024 | |
| respiratory tube development | GO:0030323 | 167 | 0.024 | |
| protein localization to organelle | GO:0033365 | 185 | 0.023 | |
| intracellular protein transport | GO:0006886 | 204 | 0.023 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.023 | |
| response to acid chemical | GO:0001101 | 111 | 0.023 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.023 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.023 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.023 | |
| sequestering of calcium ion | GO:0051208 | 18 | 0.023 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.023 | |
| dna methylation | GO:0006306 | 43 | 0.023 | |
| respiratory system development | GO:0060541 | 190 | 0.023 | |
| pallium development | GO:0021543 | 120 | 0.023 | |
| lateral inhibition | GO:0046331 | 1 | 0.023 | |
| negative regulation of cell division | GO:0051782 | 24 | 0.023 | |
| angiogenesis | GO:0001525 | 201 | 0.023 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.023 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.022 | |
| response to starvation | GO:0042594 | 65 | 0.022 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.022 | |
| gene silencing | GO:0016458 | 38 | 0.022 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.022 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.022 | |
| chromatin modification | GO:0016568 | 187 | 0.022 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.022 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.022 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.022 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.022 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.022 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.022 | |
| renal system development | GO:0072001 | 225 | 0.022 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.022 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.022 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.022 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.021 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.021 | |
| germ cell development | GO:0007281 | 185 | 0.021 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.021 | |
| negative regulation of chromosome organization | GO:2001251 | 30 | 0.021 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.021 | |
| regulation of protein transport | GO:0051223 | 163 | 0.021 | |
| glial cell differentiation | GO:0010001 | 131 | 0.021 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.021 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.021 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.021 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.021 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.021 | |
| maintenance of location | GO:0051235 | 89 | 0.021 | |
| chemotaxis | GO:0006935 | 247 | 0.021 | |
| regulation of dna methylation | GO:0044030 | 12 | 0.020 | |
| cell cycle arrest | GO:0007050 | 37 | 0.020 | |
| heart morphogenesis | GO:0003007 | 178 | 0.020 | |
| rhythmic process | GO:0048511 | 174 | 0.020 | |
| action potential | GO:0001508 | 78 | 0.020 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.020 | |
| methylation | GO:0032259 | 134 | 0.020 | |
| negative regulation of nuclear division | GO:0051784 | 19 | 0.020 | |
| non recombinational repair | GO:0000726 | 10 | 0.020 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.020 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.020 | |
| adenylate cyclase modulating g protein coupled receptor signaling pathway | GO:0007188 | 54 | 0.020 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.020 | |
| macromolecule methylation | GO:0043414 | 120 | 0.020 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.020 | |
| immunoglobulin production | GO:0002377 | 73 | 0.020 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.020 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.020 | |
| histone modification | GO:0016570 | 159 | 0.020 | |
| negative regulation of proteasomal ubiquitin dependent protein catabolic process | GO:0032435 | 15 | 0.020 | |
| multicellular organism growth | GO:0035264 | 161 | 0.020 | |
| regulation of secretion | GO:0051046 | 274 | 0.020 | |
| hair follicle development | GO:0001942 | 85 | 0.020 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.020 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.020 | |
| protein acylation | GO:0043543 | 64 | 0.020 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.020 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.019 | |
| cartilage development | GO:0051216 | 140 | 0.019 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.019 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.019 | |
| activation of adenylate cyclase activity | GO:0007190 | 4 | 0.019 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.019 | |
| nuclear division | GO:0000280 | 158 | 0.019 | Worm |
| signal transduction involved in mitotic dna integrity checkpoint | GO:1902403 | 3 | 0.019 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.019 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.019 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.019 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.019 | |
| positive regulation of protein ubiquitination | GO:0031398 | 27 | 0.019 | |
| regulation of alpha beta t cell activation | GO:0046634 | 53 | 0.019 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.019 | |
| regulation of chemotaxis | GO:0050920 | 53 | 0.019 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.019 | |
| regulation of system process | GO:0044057 | 200 | 0.019 | |
| mitotic sister chromatid separation | GO:0051306 | 9 | 0.019 | |
| negative regulation of proteolysis involved in cellular protein catabolic process | GO:1903051 | 22 | 0.019 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.019 | |
| lung development | GO:0030324 | 164 | 0.019 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.019 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.018 | |
| signal transduction involved in mitotic cell cycle checkpoint | GO:0072413 | 3 | 0.018 | |
| cell adhesion | GO:0007155 | 329 | 0.018 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.018 | |
| kidney development | GO:0001822 | 213 | 0.018 | |
| adaptive immune response | GO:0002250 | 155 | 0.018 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.018 | |
| wound healing | GO:0042060 | 157 | 0.018 | |
| response to inorganic substance | GO:0010035 | 96 | 0.018 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.018 | |
| mrna transcription from rna polymerase ii promoter | GO:0042789 | 4 | 0.018 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.018 | |
| cerebellum development | GO:0021549 | 77 | 0.018 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.018 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 64 | 0.018 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.018 | |
| dna alkylation | GO:0006305 | 43 | 0.018 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.018 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.018 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.018 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.018 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.018 | |
| locomotory behavior | GO:0007626 | 195 | 0.017 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.017 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.017 | |
| neuronal action potential | GO:0019228 | 54 | 0.017 | |
| metencephalon development | GO:0022037 | 89 | 0.017 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.017 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.017 | |
| activation of innate immune response | GO:0002218 | 56 | 0.017 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.017 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.017 | |
| regulation of cd4 positive alpha beta t cell activation | GO:2000514 | 24 | 0.017 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.017 | |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.017 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.017 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.017 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.017 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.017 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.017 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.017 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.017 | |
| isotype switching | GO:0045190 | 36 | 0.017 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.017 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.017 | |
| mitotic sister chromatid segregation | GO:0000070 | 14 | 0.017 | |
| organ growth | GO:0035265 | 117 | 0.017 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.017 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.017 | |
| cellular response to abiotic stimulus | GO:0071214 | 56 | 0.017 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.016 | |
| response to caffeine | GO:0031000 | 6 | 0.016 | |
| positive regulation of protein catabolic process | GO:0045732 | 60 | 0.016 | |
| lipid localization | GO:0010876 | 126 | 0.016 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.016 | |
| digestive system development | GO:0055123 | 200 | 0.016 | |
| muscle cell development | GO:0055001 | 133 | 0.016 | |
| mature dendritic cell differentiation | GO:0097029 | 3 | 0.016 | |
| bundle of his development | GO:0003166 | 4 | 0.016 | |
| regulation of intracellular protein transport | GO:0033157 | 82 | 0.016 | |
| b cell proliferation | GO:0042100 | 53 | 0.016 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.016 | |
| regulation of organ growth | GO:0046620 | 61 | 0.016 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.016 | |
| protein targeting | GO:0006605 | 143 | 0.016 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.016 | |
| placenta development | GO:0001890 | 140 | 0.016 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.016 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.016 | |
| intestinal epithelial structure maintenance | GO:0060729 | 4 | 0.016 | |
| epithelial cell development | GO:0002064 | 159 | 0.016 | |
| sister chromatid segregation | GO:0000819 | 20 | 0.016 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.016 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.016 | |
| immune effector process | GO:0002252 | 321 | 0.016 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.016 | |
| positive regulation of t cell differentiation | GO:0045582 | 52 | 0.016 | |
| positive regulation of protein modification by small protein conjugation or removal | GO:1903322 | 30 | 0.016 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.016 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.016 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.016 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.016 | |
| mitotic spindle checkpoint | GO:0071174 | 9 | 0.016 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.016 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.015 | |
| regulation of cyclic nucleotide metabolic process | GO:0030799 | 40 | 0.015 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.015 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.015 | |
| spermatid differentiation | GO:0048515 | 115 | 0.015 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.015 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.015 | |
| body fluid secretion | GO:0007589 | 53 | 0.015 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.015 | |
| digestive tract development | GO:0048565 | 190 | 0.015 | |
| negative regulation of growth | GO:0045926 | 99 | 0.015 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.015 | |
